NCT05326464 2025-12-15
Tofacitinib in Recurrent GBM Patients
University of Texas Southwestern Medical Center
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT06698822 2025-12-15
A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT04431895 2025-09-16
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
Huashan Hospital
Phase EARLY_PHASE1 Completed